- Home
- ARBE vs SERA Comparison
ARBE vs SERA Comparison
Compare ARBE & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBE | SERA |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1M | 75.2M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARBE | SERA |
|---|---|---|
| Price | $0.90 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.38 | N/A |
| AVG Volume (30 Days) | ★ 874.0K | 18.9K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | $363.94 | $554.81 |
| Revenue Next Year | $286.43 | $517.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $0.55 | $1.37 |
| 52 Week High | $2.88 | $4.09 |
Technical Indicators
Market Signals| Indicator | ARBE | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 61.06 | 35.80 |
| Support Level | $0.74 | N/A |
| Resistance Level | $1.46 | $2.41 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 79.38 | 17.39 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.